Using millers, barasch and Morgan anaesthesia books discuss in details about Mitral stenosis/ Mitral regurgitation in Pregnancy

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Files

Browsing Directory

Mitral Stenosis & Mitral Regurgitation in Pregnancy

A Comprehensive Anaesthesia Perspective from Miller's, Barash, and Morgan & Mikhail

PART I — PHYSIOLOGICAL CHANGES OF PREGNANCY RELEVANT TO VALVULAR DISEASE

Understanding why mitral valve disease becomes so precarious in pregnancy requires a firm grasp of the normal cardiovascular adaptations:

Parameter	Change in Pregnancy
Plasma volume	↑ 50–55% by term
Cardiac output	↑ 35–40% by end of 1st trimester; ↑ 40–50% by end of 2nd trimester
Stroke volume	↑ 25–30%
Heart rate	↑ 15–25%
SVR	↓ (due to low-resistance uteroplacental circulation)
Colloid osmotic pressure	↓ from 27 → 22 mm Hg

Miller's (10e, p. 8803): By end of the first trimester, cardiac output typically increases approximately 35–40% above pre-pregnancy values, continuing to increase 40–50% by the end of the second trimester, driven by increases in both stroke volume (25–30%) and heart rate (15–25%). Labor further augments cardiac output — 10–25% above prelabour values during the first stage and 40% in the second stage. The largest single increase occurs immediately after delivery, when cardiac output can jump by 80%.

Barash (9e, p. 3522): Pregnancy-induced increases in blood volume, heart rate, and CO contribute to pulmonary oedema, heart failure, arrhythmias, and even death in patients with left-sided stenotic lesions, with the greatest risk during labour and immediately following delivery. In contrast, regurgitant lesions are generally well tolerated — the decreased afterload associated with pregnancy and neuraxial procedures can actually improve maternal haemodynamics in MR.

PART II — MITRAL STENOSIS IN PREGNANCY

2.1 Pathophysiology of Mitral Stenosis

Miller's (10e, p. 7613): The disease process of rheumatic MS includes thickening, commissural fusion, and increased rigidity of the mitral valve leaflets, as well as thickening, fusion, and contracture of the chordae and papillary heads. With long-standing disease, calcification of the valve apparatus inevitably occurs.

Normal mitral valve orifice area: 4–5 cm²
Symptoms may occur when MVA < 2.5 cm²
Symptoms at rest when MVA < 1.5 cm²
Precipitants of acute decompensation: stress, exercise, anaemia, pregnancy, febrile illness

Grade	MVA (cm²)
Mild	>1.5
Moderate	1.0–1.5
Severe	<1.0

The transmitral pressure gradient is flow-dependent. Elevated flow states — such as pregnancy — can dramatically increase the pressure gradient and left atrial pressure (LAP). From the modified Bernoulli equation (ΔP = 4v²), any increase in transvalvular flow rate from an elevated heart rate has a compounding impact on transvalvular dynamics and LAP.

Obstructed mitral inflow → ↑ LAP → LA enlargement → atrial fibrillation + thromboembolism + pulmonary venous hypertension → right heart failure.

2.2 Why Pregnancy Is a Crisis Point in MS

Miller's (10e, p. 7621): Elevated flow states such as pregnancy and increased sympathetic activity dramatically increase the pressure gradient across the valve, reflected in elevated LAP or pulmonary venous pressure. In MS, tachycardia is particularly dangerous: it decreases diastolic filling time while simultaneously raising flow rate across the stenotic valve — a doubly deleterious effect.

Miller's (10e, p. 8892): Moderate to severe mitral stenosis, alongside pulmonary hypertension, severe LVOTO, and cyanotic congenital heart disease, carries significant risk for maternal morbidity and mortality.

Barash (9e, p. 3521–3522): Symptoms of left-sided stenotic lesions are exacerbated by the physiologic changes of pregnancy. Pregnancy-induced increases in blood volume, heart rate, and CO contribute to pulmonary oedema, heart failure, arrhythmias, and even death in these patients.

Creasy & Resnik (quoted from DB): Pregnancy drastically stresses the circulation in women with severe MS and is therefore contraindicated (WHO class IV). The increased blood volume, heart rate, and cardiac output raise left atrial pressure to a level that causes severe pulmonary congestion.

2.3 Haemodynamic Goals in MS During Pregnancy

Barash (9e) Table 41-6 — Haemodynamic Goals:

Goal	Rationale
Sinus rhythm	Loss of atrial kick in AF → precipitous drop in CO
↓ Heart rate (60–80 bpm)	Longer diastolic filling time across stenotic valve
Maintain SVR	Hypotension → reflex tachycardia → worsens gradient
Maintain venous return/preload	But judicious — excess volume → pulmonary oedema

Miller's (10e, p. 7620–7621): The heart rate should be kept within its normal range. Tachycardia may be poorly tolerated because of the decreased time for diastolic filling. Moreover, pressure gradients are somewhat flow-dependent in MS. Elevated flow states can dramatically increase the gradient.

2.4 Anaesthetic Management of MS in Labour and Delivery

Miller's (10e, p. 7620): Primary concerns in patients with MS include managing ventricular preload, heart rate, and coexisting pulmonary hypertension, as well as potentially diminished RV and LV contractile function. Most patients with valvular heart disease have increased dependency on and sensitivity to ventricular preload. Flow through a stenotic mitral valve requires a higher-than-normal pressure gradient between the left atrium and left ventricle. Reduction in preload from blood loss or vasodilatory effects of anaesthesia can markedly affect stroke volume, CO, and tissue perfusion. However, in higher grades of MS, LAP may be very high, and the difference between adequate filling pressure and an LAP that leads to congestive failure may be small — judicious fluid management is required.

Monitoring (Miller's, p. 7622): Standard ASA monitors + invasive arterial blood pressure + CVP + intraoperative echocardiography. PA catheter monitoring of CO may be very helpful but must be used with care given the propensity for PA rupture in patients with long-standing pulmonary hypertension.

Miller's (10e, p. 8892–8893) — labour analgesia: When atrial fibrillation or pulmonary hypertension is present or suspected, more intensive monitoring (5-lead ECG, intra-arterial BP) should be considered. Neuraxial analgesia (epidural) is the preferred technique for labour — it attenuates the sympathetic and catecholamine surge from pain-related tachycardia, which is especially destructive in MS.

Morgan (7e, DB snippet): The haemodynamic goals for MS emphasise sinus rhythm, ↓ HR, maintenance of SVR, and maintenance of venous return. For neuraxial analgesia, slowly titrated epidural is preferred over single-shot spinal (which produces rapid SVR drop and reflex tachycardia). For caesarean delivery under neuraxial or general anaesthesia, the priority is to avoid tachycardia and hypotension.

Neuraxial vs General Anaesthesia in MS

Technique	Considerations in MS
Epidural (preferred)	Slow, titratable onset; avoids acute SVR drop; controls pain → prevents tachycardia
Spinal (caution)	Rapid sympathectomy → ↓ SVR → reflex tachycardia → dangerous in severe MS
General anaesthesia	Intubation → tachycardia (laryngoscopy response); volatile agents → vasodilation; but allows complete airway control

Drugs to Avoid in MS

Atropine / glycopyrrolate — cause tachycardia
Ketamine — sympathomimetic, raises HR
Pancuronium — vagolytic, raises HR
Ephedrine (cautious use) — increases HR; phenylephrine is preferred vasopressor to treat hypotension

Tachycardia Control

Beta-blockers (metoprolol, esmolol) are the first-line agents — control rate and, via negative inotropy, reduce left atrial pressure
Digoxin for rate control in AF
Cardioversion for haemodynamically significant AF

2.5 Interventional Management During Pregnancy

Miller's (10e, p. 8920–8921): Percutaneous balloon valvuloplasty may obviate open cardiac intervention in pregnancy and has been associated with reduced fetal and neonatal mortality. If cardiac surgery with cardiopulmonary bypass (CPB) becomes unavoidable:

Higher pump flows (>2.5 L/min/m²) and perfusion pressures (>70 mm Hg) recommended to support uteroplacental blood flow
Normothermic bypass and pulsatile flow better preserve uteroplacental perfusion
Hypothermic bypass is associated with greater fetal loss
Hypocapnia should be avoided (causes uterine vasoconstriction)
Continuous fetal heart rate monitoring during CPB is recommended

2.6 Mode of Delivery in MS

Miller's (10e, p. 8893): Patients with stable cardiac disease can nearly always undergo vaginal delivery, with caesarean delivery reserved for obstetric indications.

Barash (9e): An individualised plan should be determined between 20–30 weeks gestation via shared decision-making involving the patient, obstetrician, anaesthesiologist, and cardiologist ("pregnancy heart team" — ACOG recommendation).

For vaginal delivery: Epidural analgesia is ideal — controls pain (prevents tachycardia), reduces cardiac work, and can be extended for operative delivery if needed.

Postpartum considerations: The auto-transfusion effect of uterine involution and offloading of aortocaval compression sharply increases venous return — patients with MS may develop acute pulmonary oedema in the immediate postpartum period and require close haemodynamic monitoring for 24–48 hours.

PART III — MITRAL REGURGITATION IN PREGNANCY

3.1 Aetiology and Classification

Miller's (10e, p. 7622–7623): MR can be classified as organic (intrinsic valvular disease) or functional (related to non-valvular components). The mitral apparatus consists of six primary components: LA wall, annulus, mitral valve leaflets, chordae tendineae, papillary muscles, and LV wall. Abnormality in any component can produce mitral valve incompetence.

Common causes:

Myxomatous degeneration — annular dilation, chordal elongation/rupture, prolapsing/flail leaflets (most common in developed countries)
Ischaemic MR — 10–20% of patients with CAD; no morphological leaflet abnormality
Rheumatic disease — annular/LV dilation + leaflet coaptation abnormality
Carpentier classification (Miller's, p. 7631): Type I (annular dilation, normal leaflets), Type II (excess leaflet motion — most common), Type IIIa (fibrosis of subvalvular apparatus), Type IIIb (leaflet tethering from ventricular remodelling)

3.2 Pathophysiology of MR

Miller's (10e, p. 7623–7631): The incompetent mitral valve allows retrograde passage of blood from the left ventricle into the left atrium during systole. The magnitude of the regurgitant volume is a function of:

Size of the regurgitant orifice
Pressure differential between LA and LV
Duration of the regurgitant cycle

Higher systolic driving pressures (e.g., hypertension) increase regurgitant volume. In chronic compensated MR, the LA dilates to accommodate the regurgitant volume, maintaining a low LAP for a prolonged period. The LV undergoes eccentric hypertrophy, maintaining high stroke volume and a high (but deceptively so) ejection fraction. Eventually, LA pressure thresholds are exceeded → elevated PAP → RV enlargement → RV dysfunction.

EF indices are poorly correlated with true LV systolic function in moderate-to-severe MR — underlying systolic dysfunction may be underestimated.

3.3 Why MR Is Generally Better Tolerated in Pregnancy

Barash (9e, p. 3522): In contrast to stenotic lesions, valvular regurgitant lesions are generally well tolerated during pregnancy. The decreased afterload associated with pregnancy and neuraxial procedures can actually improve maternal haemodynamics in MR.

Miller's (10e, p. 8892): During pregnancy, labour, and delivery, regurgitant valvular lesions are generally tolerated better than stenotic valvular lesions.

The physiologic mechanisms explaining this:

↓ SVR (pregnancy) → ↓ regurgitant fraction → more blood goes forward
↑ HR (pregnancy) → shortens systolic period → less time for regurgitation per beat
Overall forward CO is maintained or improved

However, severe MR with ventricular dysfunction is not well tolerated and requires careful anaesthetic planning.

3.4 Haemodynamic Goals in MR During Pregnancy

Barash (9e) Table 41-6 — Haemodynamic Goals for Mitral Insufficiency:

Goal	Rationale
Sinus rhythm	AF → haemodynamic deterioration; less catastrophic than in MS but still important
Mild ↑ HR (80–100 bpm)	Shortens systole → reduces regurgitant time; prevents LV dilation
Avoid ↑ SVR	High afterload → increases regurgitant fraction
Avoid ↑ venous return (excess preload)	Ventricular distention expands dilated annulus → worsens MR

Miller's (10e, p. 7633–7634):

Heart rate should be maintained in the high-normal range (80–100 bpm)
Bradycardia is doubly detrimental: it lengthens the systolic period (prolonging regurgitation) AND increases diastolic filling (causing LV dilation → worsening annular MR)
Sinus rhythm preferred but less critical for atrial kick than in stenotic disease
Afterload reduction is a cornerstone: forward CO is maximised by lowering SVR
Avoid direct-acting α1 agonists — increase SVR, lower HR, and may worsen MR; ephredrine may be used temporarily but inotropic support is preferred for persistent hypotension
Acceptable inotropes: dobutamine, low-dose epinephrine, milrinone

3.5 Anaesthetic Management of MR in Labour and Delivery

Miller's (10e, p. 7633): In chronic, compensated MR, maintaining preload, judiciously reducing afterload, and keeping the heart rate in the high-normal range may be adequate.

Neuraxial anaesthesia is particularly well-suited to MR because:

Neuraxial techniques ↓ SVR → reduces regurgitant fraction → improves forward flow
Epidural provides gradual, titratable onset without abrupt haemodynamic swings
Pain control prevents the catecholamine surge that would raise SVR and reduce HR

For hypotension management in MR:

Ephedrine (combined α and β) is more appropriate than phenylephrine (pure α-agonist), which increases SVR and can worsen MR
Small doses of milrinone (inodilator) may be ideal in decompensated MR — reduces PVR and afterload while improving contractility

Monitoring (Miller's, p. 7622, 7634): Standard monitors + invasive arterial BP. Intraoperative TEE is especially important for evaluating:

Severity of MR under anaesthetic conditions (loading conditions altered by anaesthesia can dramatically change the apparent severity)
LV systolic function (EF overestimates true contractility in MR)
RV size and function
Decision about need for valve repair/replacement

Miller's (p. 7634): Both PAP and PVR may be elevated in patients with either acute or long-standing MR. Factors that may increase PVR (hypoxia, hypercarbia, acidosis) should be actively corrected.

3.6 Acute Severe MR in Pregnancy

In the rare event of acute, severe MR (e.g., papillary muscle rupture from ischaemic disease or spontaneous coronary artery dissection — a pregnancy-specific complication), the pathophysiology is vastly different from chronic MR:

The LA has not had time to dilate → sudden massive increase in LAP → acute pulmonary oedema
LV is not yet hypertrophied → cardiogenic shock

Miller's (10e, p. 7634–7635): In the patient with acute, severe MR and cardiogenic shock from ischaemic rupture of a papillary muscle, pharmacologic support of the left ventricle, often accompanied by mechanical support with IABP counterpulsation, may be necessary.

3.7 Postpartum Considerations in MR

Auto-transfusion of uterine blood (400–500 mL) at delivery → sudden increase in preload → potential volume overload with acute decompensation if LV function is already impaired
Oxytocin: use cautiously (causes vasodilation and tachycardia); ergometrine is contraindicated in patients with valvular disease due to severe hypertension and coronary spasm risk

PART IV — COMPARATIVE TABLE: MS vs MR IN PREGNANCY

Feature	Mitral Stenosis	Mitral Regurgitation
Tolerance of pregnancy	Poorly tolerated; can be WHO class IV if severe	Generally well tolerated; severe MR with LV dysfunction is risky
Primary haemodynamic threat	Pulmonary oedema from elevated LAP	Forward failure if LV dysfunction present
Effect of ↑ HR in pregnancy	Devastating (↑ gradient, ↑ LAP)	Beneficial (↓ regurgitant time per beat)
Effect of ↓ SVR (pregnancy)	Reflex tachycardia dangerous	Beneficial (↓ regurgitant fraction)
Effect of ↑ preload (pregnancy)	Dangerous (pulmonary congestion)	Generally tolerated if LV not dilated
Target HR	60–80 bpm (slow, low)	80–100 bpm (high-normal)
Target SVR	Maintain/high	Reduce/low
Vasopressor of choice	Phenylephrine (no tachycardia)	Ephedrine (avoid pure α agents)
Neuraxial preferred?	Yes — epidural (not spinal)	Yes — both beneficial
Atrial fibrillation	Rate control critical; cardioversion if unstable	Less immediately catastrophic but still treat
Most dangerous period	Labour + immediate postpartum	Immediate postpartum (auto-transfusion)
CPB if required	Normothermic, high flow, pulsatile, avoid hypocapnia	Same principles apply

PART V — ANTICOAGULATION IN PREGNANCY (Mechanical Valves/AF)

Barash (9e, p. 3523): In patients requiring therapeutic anticoagulation (mechanical valves, AF with MS):

Warfarin is often discontinued during the 1st trimester due to teratogenic effects but is usually restarted during the 2nd trimester and continued to near term
Warfarin is transitioned to unfractionated heparin (UFH) prior to delivery
SOAP guidelines: Hold IV UFH 4–6 hours before neuraxial procedure; hold LMWH 24 hours before neuraxial

PART VI — MODIFIED WHO RISK CLASSIFICATION

Miller's (10e, p. 8892): The modified WHO risk stratification system appears to perform best in predicting maternal morbidity or mortality during pregnancy and delivery and should guide decisions about tertiary referral.

WHO Class	Examples	Risk
I	Mild PS, repaired simple lesions	No detectable increased risk
II	Repaired ToF, mild MS	Small increased risk
III	Moderate MS, mechanical valve	Significant increased risk; specialist centre
IV	Severe MS, severe MR with LV dysfunction, Eisenmenger's	Extremely high risk; pregnancy contraindicated

PART VII — KEY CLINICAL PEARLS (Summary from all three books)

From Miller's Anaesthesia, 10e:

In MS, any elevated flow state (pregnancy, fever, pain, anxiety) can trigger a haemodynamic crisis via the modified Bernoulli equation
EF overestimates true LV contractility in MR — do not be reassured by a normal EF in severe MR
TEE is the intraoperative cornerstone for both MS and MR assessment
CPB during pregnancy: normothermic, pulsatile, high-flow (>2.5 L/min/m²), high MAP (>70 mmHg), avoid hypocapnia

From Barash Clinical Anaesthesia, 9e:

Maternal morbidity and mortality are greatest with left-sided stenotic valvular lesions and those accompanied by ventricular dysfunction or pulmonary hypertension
Regurgitant lesions are generally well tolerated — neuraxial afterload reduction is beneficial in MR
The "pregnancy heart team" (obstetrician + anaesthesiologist + cardiologist) should establish a delivery plan between 20–30 weeks gestation
Anticoagulation transition plan must be in place well before labour

From Morgan & Mikhail's Clinical Anaesthesiology, 7e:

Haemodynamic goal table highlights the critical opposition between MS (↓ HR, maintain SVR, maintain preload) and MR (↑ HR, ↓ SVR, cautious preload)
Single-shot spinal anaesthesia is not recommended for patients with severe left-sided stenotic lesions due to abrupt SVR reduction
PAH in pregnancy: maternal mortality 16–30%; neuraxial analgesia useful but single-shot spinal avoided; most deaths occur during labour or the early postpartum period

References

Miller's Anaesthesia, 10th Edition (2025) — Chapter 50 (Valvular Heart Disease), Chapter 58 (Obstetric Anaesthesia)
Barash, Cullen & Stoelting's Clinical Anaesthesia, 9th Edition — Chapter 41 (Obstetric Anaesthesia)
Morgan & Mikhail's Clinical Anaesthesiology, 7th Edition — Obstetric Anaesthesia chapter (Valvular Heart Disease in Pregnancy section)

This is a shared conversation. Sign in to Orris to start your own chat.